Our Team

Dr. Alexey Bersenev is a Co-founder and Chief Technology Officer (CTO) at Cell BioEngines and oversees company's CGT process development programs, CMC operations and bio-manufacturing. In addition to his position at Cell BioEngines, he serves as a Director of the Advanced Cell Therapy Lab at Yale-New Haven Hospital and is an Assistant Professor of Clinical Laboratory Medicine at the Department of Laboratory Medicine at Yale University.

Prior to joining Yale, Dr. Bersenev worked as a cell manufacturing specialist at the University of Pennsylvania and trained in clinical cell processing in a GMP cell manufacturing facility and was involved in the manufacture of first CAR T-cell products for clinical trials and technology transfer to Novartis. He has expertise in clinical manufacturing of cellular products for clinical trials, including product and process development, cell processing and culture, operations of academic GMP facility and compliance with regulations.

Dr. Bersenev received his medical education and certification as a general surgeon in Russia. He holds a PhD in transplantation/ pathology. He gained expertise in immunology, hematology, stem cell biology and published scientific papers during post-doctoral training in the US in Philadelphia at the Thomas Jefferson University and the Children’s Hospital of Philadelphia.